↓ Skip to main content

Could a Long-Acting Prodrug of SN-38 be Efficacious in Sacituzumab Govitecan-Resistant Tumors?

Overview of attention for article published in BioDrugs, January 2024
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#21 of 723)
  • High Attention Score compared to outputs of the same age (95th percentile)

Mentioned by

news
5 news outlets

Readers on

mendeley
1 Mendeley